Anti-VEGF agents in the treatment of diabetic macular edema
Diabetic macular edema (DME) is a common complication associated with the loss of visual acuity in diabetic patients. Intravitreal injections of vascular endothelium growth factor (VEGF) inhibitors (anti-VEGF therapy) have been proposed recently as a new treatment option for patients with DME. In th...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2013-12-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/3871 |